AstraZeneca COPD drug tozorakimab shows positive late-stage trial results

AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for chronic obstructive pulmonary disease, boosting hopes that it could generate multibillion-dollar sales for the company.  The biologic medicine, tozorakimab, is under priority review by the Food and Drug Administration, with U.S. approval expected in the first quarter of 2027….

Read Full News

JLR to cut thousands of jobs in cost-saving drive

General view of Land Rover cars outside the Jaguar Land Rover factory on April 7, 2025 in Halewood, England. Richard Martin-roberts | Getty Images News | Getty Images Thousands of workers at Britain’s Jaguar Land Rover (JLR) will be offered voluntary redundancies as the luxury car manufacturer responds to intense competition from cheaper Chinese rivals,…

Read Full News